APA (7th ed.) Citation

Vermeire, S., Hanzel, J., Löwenberg, M., Ferrante, M., Bossuyt, P., Hoentjen, F., . . . group, L. s. (2024). Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes. Journal of Crohn's & Colitis, 18(4), 540. https://doi.org/10.1093/ecco-jcc/jjad179

Chicago Style (17th ed.) Citation

Vermeire, Séverine, et al. "Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes." Journal of Crohn's & Colitis 18, no. 4 (2024): 540. https://doi.org/10.1093/ecco-jcc/jjad179.

MLA (9th ed.) Citation

Vermeire, Séverine, et al. "Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes." Journal of Crohn's & Colitis, vol. 18, no. 4, 2024, p. 540, https://doi.org/10.1093/ecco-jcc/jjad179.